STAT3 and ovarian cancer: The delivery of shRNA against STAT3 in liposomes resulted in a reduction in the growth of intraperitoneal ovarian cancer through the inhibition of cell proliferation and apoptosis induction [72], while the delivery of siRNA against NOTCH1 in cationic cholesterol derivative-based liposomes led to the inhibition of growth and apoptosis induction in vitro [73].